Predict your next investment

Venture Capital
versantventures.com

See what CB Insights has to offer

Investments

544

Portfolio Exits

120

Funds

28

Partners & Customers

5

Service Providers

2

About Versant Ventures

Versant Ventures is a healthcare investment firm committed to helping entrepreneurs build the healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $1.9 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building.

Versant Ventures Headquarter Location

One Sansome Street Suite 3630

San Francisco, California, 94104,

United States

415-801-8100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Versant Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Versant Ventures in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Research containing Versant Ventures

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Versant Ventures in 3 CB Insights research briefs, most recently on Feb 2, 2021.

Latest Versant Ventures News

Versant Ventures Investments

544 Investments

Versant Ventures has made 544 investments. Their latest investment was in Cimeio Therapeutics as part of their Series A on April 4, 2022.

CBI Logo

Versant Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/13/2022

Series A

Cimeio Therapeutics

$50M

Yes

5

2/9/2022

Series C

Ventus Therapeutics

$140M

No

15

12/2/2021

Series B

CODA Biotherapeutics

$28M

No

6

11/30/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/19/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/13/2022

2/9/2022

12/2/2021

11/30/2021

11/19/2021

Round

Series A

Series C

Series B

Series A

Series B

Company

Cimeio Therapeutics

Ventus Therapeutics

CODA Biotherapeutics

Subscribe to see more

Subscribe to see more

Amount

$50M

$140M

$28M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

15

6

10

10

Versant Ventures Portfolio Exits

120 Portfolio Exits

Versant Ventures has 120 portfolio exits. Their latest portfolio exit was Minerva Surgical on October 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/22/2021

IPO

$99M

10

9/21/2021

Acquired

2

8/5/2021

Acquired

$99M

13

7/30/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

6/25/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/22/2021

9/21/2021

8/5/2021

7/30/2021

6/25/2021

Exit

IPO

Acquired

Acquired

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

10

2

13

10

10

Versant Ventures Fund History

28 Fund Histories

Versant Ventures has 28 funds, including Versant Venture Capital VIII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/21/2021

Versant Venture Capital VIII

$560M

1

4/21/2021

Versant Vantage II

$240M

2

11/18/2020

Versant Venture Capital VII

$600M

3

8/13/2019

Versant Voyageurs I

Subscribe to see more

Subscribe to see more

$99M

10

4/24/2018

Versant Voyageurs I Feeder

$99M

10

Closing Date

4/21/2021

4/21/2021

11/18/2020

8/13/2019

4/24/2018

Fund

Versant Venture Capital VIII

Versant Vantage II

Versant Venture Capital VII

Versant Voyageurs I

Versant Voyageurs I Feeder

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$560M

$240M

$600M

$99M

$99M

Sources

1

2

3

10

10

Versant Ventures Partners & Customers

5 Partners and customers

Versant Ventures has 5 strategic partners and customers. Versant Ventures recently partnered with Chinook Therapeutics on November 11, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

11/30/2021

Partner

Canada

Chinook Therapeutics Announces Formation of SanReno Therapeutics, a Joint Venture to Develop Kidney Disease Therapies in China

30 , 2021 -- Chinook Therapeutics , Inc. , a biopharmaceutical company focused on the discovery , development and commercialization of precision medicines for kidney diseases , today announced the formation of SanReno , a joint venture with an investor syndicate led by Frazier Healthcare Partners , to develop , manufacture and commercialize kidney disease therapies in the People 's Republic of China , Hong Kong , Macau , Taiwan and Singapore .

1

2/15/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

12/12/2016

Partner

Germany

Subscribe to see more

Subscribe to see more

10

6/23/2014

Partner

United States, and Switzerland

Subscribe to see more

Subscribe to see more

10

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

11/30/2021

2/15/2017

12/12/2016

6/23/2014

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

Canada

United States

Germany

United States, and Switzerland

United States

News Snippet

Chinook Therapeutics Announces Formation of SanReno Therapeutics, a Joint Venture to Develop Kidney Disease Therapies in China

30 , 2021 -- Chinook Therapeutics , Inc. , a biopharmaceutical company focused on the discovery , development and commercialization of precision medicines for kidney diseases , today announced the formation of SanReno , a joint venture with an investor syndicate led by Frazier Healthcare Partners , to develop , manufacture and commercialize kidney disease therapies in the People 's Republic of China , Hong Kong , Macau , Taiwan and Singapore .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Versant Ventures Service Providers

2 Service Providers

Versant Ventures has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

Provider Type

Counsel

Subscribe to see more

Service Type

General Counsel

Subscribe to see more

Partnership data by VentureSource

Versant Ventures Team

23 Team Members

Versant Ventures has 23 team members, including current Founder, Managing Director, Brian G Atwood.

Name

Work History

Title

Status

Brian G Atwood

Founder, Managing Director

Current

Barbara N. Lubash

Crosspoint Venture Partners

Founder

Current

Rebecca B. Robertson

Institutional Venture Partners, and Egis

Founder, Managing Director

Current

Kristin Beach

Controller

Current

Candace Chan

Controller

Current

Name

Brian G Atwood

Barbara N. Lubash

Rebecca B. Robertson

Kristin Beach

Candace Chan

Work History

Crosspoint Venture Partners

Institutional Venture Partners, and Egis

Title

Founder, Managing Director

Founder

Founder, Managing Director

Controller

Controller

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.